Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

IpiGlio: A Phase II, Open Label, Randomised Study of Ipilimumab with Temozolomide versus Temozolomide alone after surgery and chemoradiotherapy in patients with recently diagnosed glioblastoma

IPI-GLIO trial logo

Primary Publication

Neuro-Oncology Advances 26 May 2025

Ipilimumab with temozolomide vs temozolomide alone after surgery and chemoradiotherapy in recently diagnosed glioblastoma: a randomised phase II clinical trial

lay summary

A lay summary of the Ipi-Glio trial can be found on the CRUK website at this link:

https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-of-ipilimumab-and-temozolomide-for-people-with-glioblastoma-ipi-glio#undefined